PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors?

Reported by Yahoo Finance · Published 16 Sep 2026, 12:43 AM MYT (6 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

OpenAI mulls funding round at $1.2 trillion valuation ahead of IPO, FT reports 52 min ago Meta plans to launch camera-free smart glasses for fall, The Information reports 56 min ago Nvidia boss says AI 'doesn't need new laws' as safety concerns grow 1 hr ago OpenAI backs bills in US Congress on AI and biological weapon threats 1 hr ago There were many conductors in the derailment of the crypto industry's Clarity Act 1 hr ago Gucci owner Kering is backing Chinese fashion brand Icicle. Can it become a global luxury name? 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors?

Summary

More in Markets

These 4 stocks could benefit most from a $3.2 trillion semiconductor opportunity

Inflation killed the penny. Now it’s coming for your dollar.

2 charts showing how oil is becoming the global market’s biggest wild card

Why a Federal Reserve rate hike could be a ‘rare win’ for your retirement money

Top Senate Republican floats a diesel export ban as prices soar. It might not work.

Oracle’s stock falls for the fifth day in a row — missing out on the AI bounce